A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.
This study has been completed.
Information provided by:
First received: January 18, 2007
Last updated: January 15, 2010
Last verified: January 2010
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||October 2009|
|Estimated Primary Completion Date:||No date given|